Literature DB >> 19187441

p53-dependent control of cell death by nicastrin: lack of requirement for presenilin-dependent gamma-secretase complex.

Raphaëlle Pardossi-Piquard1, Julie Dunys, Emilie Giaime, Marie-Victoire Guillot-Sestier, Peter St George-Hyslop, Frédéric Checler, Cristine Alves da Costa.   

Abstract

Nicastrin (NCT) is a component of the presenilin (PS)-dependent gamma-secretase complexes that liberate amyloid beta-peptides from the beta-Amyloid Precursor Protein. Several lines of evidence indicate that the members of these complexes could also contribute to the control of cell death. Here we show that over-expression of NCT increases the viability of human embryonic kidney (HEK293) cells and decreases staurosporine (STS)- and thapsigargin (TPS)-induced caspase-3 activation in various cell lines from human and neuronal origins by Akt-dependent pathway. NCT lowers p53 expression, transcriptional activity and promoter transactivation and reduces p53 phosphorylation. NCT-associated protection against STS-stimulated cell death was completely abolished by p53 deficiency. Conversely, the depletion of NCT drastically enhances STS-induced caspase-3 activation and p53 pathway and favored p53 nuclear translocation. We examined whether NCT protective function depends on PS-dependent gamma-secretase activity. First, a 29-amino acid deletion known to reduce NCT-dependent amyloid beta-peptide production did not affect NCT-associated protective phenotype. Second, NCT still reduces STS-induced caspase-3 activation in fibroblasts lacking PS1 and PS2. Third, the gamma-secretase inhibitor DFK167 did not affect NCT-mediated reduction of p53 activity. Altogether, our study indicates that NCT controls cell death via phosphoinositide 3-kinase/Akt and p53-dependent pathways and that this function remains independent of the activity and molecular integrity of the gamma-secretase complexes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19187441     DOI: 10.1111/j.1471-4159.2009.05952.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

1.  Nicastrin regulates breast cancer stem cell properties and tumor growth in vitro and in vivo.

Authors:  Ylenia Lombardo; Aleksandra Filipović; Gemma Molyneux; Manikandan Periyasamy; Georgios Giamas; Yunhui Hu; Pritesh S Trivedi; Jayson Wang; Ernesto Yagüe; Loren Michel; R Charles Coombes
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-24       Impact factor: 11.205

Review 2.  Parkin as a Molecular Bridge Linking Alzheimer's and Parkinson's Diseases?

Authors:  Frédéric Checler; Cristine Alves da Costa
Journal:  Biomolecules       Date:  2022-04-09

Review 3.  The γ-secretase complex: from structure to function.

Authors:  Xian Zhang; Yanfang Li; Huaxi Xu; Yun-Wu Zhang
Journal:  Front Cell Neurosci       Date:  2014-12-11       Impact factor: 5.505

Review 4.  P53 Dysfunction in Neurodegenerative Diseases - The Cause or Effect of Pathological Changes?

Authors:  Aleksandra Szybińska; Wiesława Leśniak
Journal:  Aging Dis       Date:  2017-07-21       Impact factor: 6.745

5.  The identification of a TNBC liver metastasis gene signature by sequential CTC-xenograft modeling.

Authors:  Monika Vishnoi; Nikki Haowen Liu; Wei Yin; Debasish Boral; Antonio Scamardo; David Hong; Dario Marchetti
Journal:  Mol Oncol       Date:  2019-06-19       Impact factor: 6.603

6.  Stretching magnitude-dependent inactivation of AKT by ROS led to enhanced p53 mitochondrial translocation and myoblast apoptosis.

Authors:  Jing Song; Yaqi Wang; Xiao Yuan; Qiuxia Ji; Cunhui Fan; Hongmei Zhao; Wenjing Hao; Dapeng Ren
Journal:  Mol Biol Cell       Date:  2019-03-13       Impact factor: 4.138

7.  Nanoscale organization of Nicastrin, the substrate receptor of the γ-secretase complex, as independent molecular domains.

Authors:  Shekhar Kedia; Kousik Mandal; Pallavi Rao Netrakanti; Mini Jose; Sangram S Sisodia; Deepak Nair
Journal:  Mol Brain       Date:  2021-10-13       Impact factor: 4.041

8.  Effect of nicastrin on hepatocellular carcinoma proliferation and apoptosis through PI3K/AKT signalling pathway modulation.

Authors:  Xicheng Wang; Xining Wang; Yunxiuxiu Xu; Maolin Yan; Wenxin Li; Jie Chen; Tao Chen
Journal:  Cancer Cell Int       Date:  2020-03-24       Impact factor: 5.722

9.  Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cells.

Authors:  Ylenia Lombardo; Monica Faronato; Aleksandra Filipovic; Valentina Vircillo; Luca Magnani; R Charles Coombes
Journal:  Breast Cancer Res       Date:  2014-06-11       Impact factor: 6.466

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.